Arterial hypertension epidemiology in Russia; the results of 2003-2010 federal monitoring
Abstract
Aim. To assess the dynamics of arterial hypertension (AH) prevalence in the Russian population, patients’ awareness, treatment with antihypertensive agents (AHA), treatment effectiveness, and the determinants of the latter.
Material and methods. As a part of the Federal Target Programme “Prevention and treatment of arterial hypertension in the Russian Federation”, four randomly selected population samples from various Russian regions were examined in 2003-2004, 2005-2006, 2007-2008, and 2009-2010.
Results. In the Russian population, AH prevalence was 39,7%, being higher in women (40,5%) than in men (38,0%). No significant changes in AH prevalence were observed for the analysed period. Patients’ awareness was 81,1% (82,9% in women vs. 77,9% in men). AHA therapy prevalence increased from 62,6 % to 66,1%. The most widely used AHA included ACE inhibitors, diuretics, and beta-adrenoblockers; old medications were taken by 17,7% of the patients only.
Conclusion. AH prevalence in the Russian population was 39,7% and did not change over the recent years. However, there was an increase in the percentage of patients taking AHA, as well as in the percentage of women with effectively treated AH. In addition, the treatment with recommended AHA became more prevalent. Ineffective therapy was typically due to lower education level, alcohol abuse, or co-existing risk factors.
About the Authors
R. G. Oganov
State Research Centre for Preventive Medicine
Russian Federation
Moscow
Russian Federation
Moscow
T. N. Timofeeva
State Research Centre for Preventive Medicine
Russian Federation
Moscow
Russian Federation
Moscow
I. E. Koltunov
State Research Centre for Preventive Medicine
Russian Federation
Moscow
Russian Federation
Moscow
V. V. Konstantinov
State Research Centre for Preventive Medicine
Russian Federation
Moscow
Russian Federation
Moscow
Yu. A. Balanova
State Research Centre for Preventive Medicine
Russian Federation
Moscow
Russian Federation
Moscow
A. V. Kapustina
State Research Centre for Preventive Medicine
Russian Federation
Moscow
Russian Federation
Moscow
I. N. Lelchuk
State Research Centre for Preventive Medicine
Russian Federation
Moscow
Russian Federation
Moscow
S. A. Shalnova
State Research Centre for Preventive Medicine
Russian Federation
Moscow
Russian Federation
Moscow
A. D. Deev
State Research Centre for Preventive Medicine
Russian Federation
Moscow
Russian Federation
Moscow
References
1. Stokes J, Kannel W, Wolf P, et al. Blood pressure as risk factor fjr cardiovascular disease. The Framingham Study — 30 years of follow-up. Hypertension 1989; 13 (Suppl. 1): 13-8.
2. Оганов Р.Г., Масленникова Г.Я. Смертность от сердечно-сосудистых и других хронических неинфекционных заболеваний среди трудоспособного населения России. Кардиоваск тер профил 2002; 3: 4-8.
3. Шальнова С.А., Деев А.Д., Оганов Р.Г. Факторы, влияющие на смертность от сердечно-сосудистых заболеваний в российской популяции. Кардиоваск тер профил 2005; 4(1): 4-9.
4. Шальнова С.А., Деев А.Д., Вихирева О.В. и др. Распространенность артериальной гипертонии в России. Информированность, лечение, контроль. Проф забол укреп здор 2001; 2: 3-7.
5. The Sevent Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment High Blood Pressure (JNS 7). JAMA 2003; 289(19): 2560-72.
6. Mancia G, De Backer G, Dominiczak A, et al. 2007. Guidelines for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105-87.
7. Диагностика и лечение артериальной гипертензии. Рекомендации Российского медицинского общества по артериальной гипертонии и Всероссийского научного общества кардиологов. Москва 2008.
8. Waeber B. Treatment strategy to control blood pressure optimal in hypertensive patients. Blood Pressure 2001; 10: 62-73.
9. Блужас Й., Тамошюнас А., Домаркене С. и др. Динамика основных факторов риска ишемической болезни сердца среди населения Каунаса за 20 лет (по данным программы МОНИКА). Кардиология 2004; 10: 25-31.
10. Wolf-Maier K, Cooper R, Banegas J, et al. Hypertension Prevalence and Blood Pressure Levels in European Countries, Canada, and the United States. JAMA 2003; 289: 2363-9.
11. Ong KL, Cheung BM, Man YB, et al. Prevalence, Awareness, Treatment, and Control of Hypertension Among United States Adults 1999-2004. Hypertension 2007; 49: 69-75.
12. Altun B, Arici M, Zoglu GN, et al. Prevalence, awareness, treatment, and control of hypertension in Turkey (the PatenT study) in 2003. J Hypertension 2005; 23: 1817-23.
13. Bhatt DL, Steg PG, Ohman EM, et al. International prevalence, recognition and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 2006; 295 (2): 180-9.
14. Mancia G, Ambrosioni E, Agabiti-Rosei E, et al. Blood pressure control and risk of stroke in untreated and treated hypertensive patients screened from clinical practice: results of the For Life study. J Hypertension 2005; 1575-81.
Review
For citations:
Oganov R.G., Timofeeva T.N., Koltunov I.E., Konstantinov V.V., Balanova Yu.A., Kapustina A.V., Lelchuk I.N., Shalnova S.A., Deev A.D. Arterial hypertension epidemiology in Russia; the results of 2003-2010 federal monitoring. Cardiovascular Therapy and Prevention. 2011;10(1):9-13. (In Russ.)
Views:
5561
Email this article 
